Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives $56.31 Average PT from Brokerages

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have received a consensus rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $56.31.

A number of equities analysts recently issued reports on ACHC shares. Royal Bank of Canada reduced their target price on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Barclays downgraded Acadia Healthcare from an “overweight” rating to an “equal weight” rating and cut their price target for the stock from $43.00 to $35.00 in a research report on Friday, February 28th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Finally, KeyCorp cut their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, March 3rd.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $28.54 on Wednesday. The firm has a market capitalization of $2.65 billion, a price-to-earnings ratio of 9.36, a price-to-earnings-growth ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The business has a fifty day moving average of $40.15 and a 200 day moving average of $48.31. Acadia Healthcare has a 1 year low of $27.61 and a 1 year high of $82.40.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of the business. Lindbrook Capital LLC lifted its stake in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares in the last quarter. Blue Trust Inc. lifted its stake in Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares in the last quarter. Nisa Investment Advisors LLC lifted its stake in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC lifted its stake in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after purchasing an additional 1,004 shares in the last quarter. Finally, Fifth Third Bancorp raised its position in shares of Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after buying an additional 454 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.